SEP 07, 2021 12:00 AM PDT

Researchers Harness the Power of Machine Learning to Facilitate Drug Repurposing

WRITTEN BY: Mia Wood

The biologic, Xolair, was developed to treat asthma, but was found useful for urticaria treatment, as well. The synthetic compound, meperidine (Demerol), originally tested for its antispasmodic effect, was found to be an effective painkiller. Botox, approved originally for treating crossed eyes is now a popular cosmetic approach to treating wrinkles, and it is prescribed for migraines and overactive bladders.

These examples of expanded uses of drugs raise an interesting question: What if we could set out to determine which drugs, developed for one use, could be repurposed for another? At The Ohio State University, assistant professor of machine learning and engineering, and biomedical informatics, Ping Zhang, used machine learning to demonstrate how massive amounts of data can identify drugs, and drug combinations, that will prevent stroke and heart failure in patients with coronary artery disease.

Given that the framework Zhang and his team developed can be customized to determine drug and drug combination repurposing to treat other diseases for which they are not prescribed, the potential benefits include a more time-efficient path to the marketplace. “This work shows how artificial intelligence can be used to ‘test’ a drug on a patient, and speed up hypothesis generation and potentially speed up a clinical trial,” Zhang explained.

Zhang looked to medical and insurance records for longitudinal data for millions of patients, and to deep machine learning. The computing power and an adaptive algorithm that employs causal inference theory do what is almost impossible for a human being. They not only to “crunch massive amounts of data, but also resolve confounders, such as age, disease severity, and race. “We are the first team,” Zhang said, “to introduce use of the deep learning algorithm to handle the real-world data, control for multiple confounders, and emulate clinical trials.”

 

Sources: Ohio State University News, Nature Machine Intelligence, Science Direct

About the Author
  • I am a philosophy professor and writer with a broad range of research interests.
You May Also Like
OCT 20, 2021
Plants & Animals
Processed Foods Negatively Affect Memory in Aging Brains
OCT 20, 2021
Processed Foods Negatively Affect Memory in Aging Brains
Processed foods—chips, soda, frozen meals, the kinds of foods designed to have a long shelf life and be easy to pr ...
OCT 21, 2021
Neuroscience
Phone-based Talk Therapy Eases Arthritis-related Insomnia
OCT 21, 2021
Phone-based Talk Therapy Eases Arthritis-related Insomnia
Talk therapy practice known as cognitive behavior therapy (CBT) conducted over the phone helps older adults with arthrit ...
OCT 27, 2021
Neuroscience
Very, Very Frightening: Why We Love Horror Movies
OCT 27, 2021
Very, Very Frightening: Why We Love Horror Movies
New research from Finland reveals why we love horror movies
NOV 11, 2021
Health & Medicine
In the Immortal Words of Bob Marley, "Get up! Stand Up!" For Your Mental Health
NOV 11, 2021
In the Immortal Words of Bob Marley, "Get up! Stand Up!" For Your Mental Health
Researchers find extended sitting associated with negative mental health
NOV 18, 2021
Clinical & Molecular DX
Sequencing and AI Combo Powers Up ADHD Diagnostics
NOV 18, 2021
Sequencing and AI Combo Powers Up ADHD Diagnostics
Attention-deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders. Red flags signal ...
NOV 29, 2021
Cell & Molecular Biology
Researchers Discover a New Type of Cell in the Retina
NOV 29, 2021
Researchers Discover a New Type of Cell in the Retina
Many types of cells in the eye were identified 100 years ago. But researchers found something new there.
Loading Comments...